Rechallenge of immunotherapy in non-small cell lung cancer patients — navigating indications and evolving perspectives
Magdalena Knetki-Wróblewska,
Izabela Chmielewska,
Kamila Wojas-Krawczyk
et al.
Abstract:Indications for immunotherapy in patients with non-small-cell lung cancer (NSCLC) are expanding, with an increasing number of patients receiving immunotherapy in the perioperative setting or as consolidation of radiochemotherapy. Immune checkpoint inhibitor (ICI)-based regimens are also being used more and more often in the first-line systemic setting. However, in many cases, the efficacy of immunotherapy is limited, and it is necessary to determine the optimal sequence of systemic treatment. There is some the… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.